Skip to content
Search

Latest Stories

The journey to smoking cessation: The role of the pharmacist

Smoking cessation methods and the vital role pharmacists can play as accessible healthcare professionals
Smoking Cessation

Let's explore various smoking cessation methods and the vital role pharmacists play as accessible healthcare professionals 

The journey for patients to quit smoking can be challenging, but with the right strategies and support, it is achievable. Smoking cessation is a critical step for patients towards improving overall health and well-being. We caught up with Thorrun Govind, pharmacist, TV health expert and pharmacy lawyer at Brabners for her top tips.

Govind notes that smoking is a leading cause of preventable diseases and deaths worldwide. It is associated with numerous health issues, including lung cancer, heart disease, stroke, and chronic obstructive pulmonary disease (COPD). Quitting smoking can significantly reduce the risk of these conditions and improve quality of life. Within weeks of quitting, individuals often experience improved lung function, better circulation, and enhanced sense of taste and smell. Govind advises that;


  • After 20 minutes of quitting your pulse rate, will already be starting to return to normal.
  • After 48 hours of quitting your carbon monoxide levels have dropped to that of a non-smoker. Your lungs are clearing out mucus and your senses of taste and smell are improving.
  • After 1 year your risk of heart attack will have halved compared with a smoker's.

This piece explores the various methods and benefits of smoking cessation.

Understanding the Importance of Quitting

Govind explained that the Cycle of Change is important to keep in mind. This model was developed by James Prochaska and Carlo DiClemente and there are six stages. Precontemplation-at this stage, individuals are not yet considering change. They may be unaware of the need for change or resistant to it. Contemplation: Individuals become aware of the need for change and start to think about it. They weigh up the pros and cons but have not yet committed to taking action. Preparation: At this stage, individuals intend to take action soon. They may start making small changes and plan the steps needed to achieve their goal. Action: This is the stage where individuals actively modify their behaviour and take concrete steps towards change. Maintenance: After achieving the initial goals, individuals work to sustain the new behaviour and prevent relapse.

Govind also pointed out the risk of Relapse. This stage involves returning to old behaviours and it is a common part of behaviour change. Individuals often cycle through the stages multiple times before achieving lasting change.

Quitting smoking is not without its challenges. Govind warns that withdrawal symptoms, such as irritability, anxiety, and cravings, can be intense, especially in the first few weeks. However, these symptoms typically peak within the first few days and gradually diminish over time. Utilising a combination of pharmaceutical and behavioural interventions can help manage these symptoms effectively.

Effective Smoking Cessation Strategies

  1. Pharmaceutical Interventions:
    • Nicotine Replacement Therapy (NRT): NRT products, such as patches, gum, lozenges, and inhalers, help reduce withdrawal symptoms by providing a controlled dose of nicotine without the harmful chemicals found in cigarettes.
    • Medications: Prescription medications like Varenicline (Champix) and Bupropion (Zyban) can help reduce cravings and withdrawal symptoms. These medications work by targeting nicotine receptors in the brain, making smoking less satisfying. However, it should be noted that Champix was withdrawn as a precaution, because of an impurity found in the medicine and Zyban was the same.

The UK Medicines Health and Regulatory Authority has now approved generic Varenicline. As a ‘generic’ or unbranded drug, Varenicline (made by the pharmaceutical company Teva UK) is more cost effective than Champix.

  1. Behavioural Interventions:
    • Counselling and Support Groups: Behavioural therapy, including individual counselling and support groups, can provide the necessary emotional support and coping strategies to quit smoking. These sessions often focus on identifying triggers, developing coping mechanisms, and setting realistic goals.
    • Digital and Mobile Interventions: Mobile apps and online programs may offer convenient and accessible support for smoking cessation. These tools often include features like progress tracking, motivational messages, and virtual coaching.
  2. Alternative Therapies:
    • Hypnotherapy and Acupuncture: Some individuals find alternative therapies like hypnotherapy and acupuncture helpful in managing cravings and reducing stress associated with quitting smoking. While the evidence on their effectiveness is mixed, they can be beneficial as part of a comprehensive cessation plan.

Conclusion

Smoking cessation is a journey that requires commitment, support, and the right strategies. Govind highlights the important role that pharmacists have as an accessible healthcare professional. However, she also encourages pharmacists to utilise their teams and ensure that the whole team is geared up for conversations on smoking cessation.  By understanding the importance of quitting, exploring various cessation methods, and seeking professional help, individuals can successfully overcome nicotine addiction and enjoy a healthier, smoke-free life.

image

Thorrun Govind, pharmacist, TV health expert and pharmacy lawyer at Brabners 

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less